Assessment of Data Regarding Thalassemias and Hemoglobin Variants From a Tertiary Referral Hospital Laboratory in Turkey

ÖZER, Nejla; GÜNGÖREN, Merve Sibel; AKÖZ, MEHMET; BALCI, Tevfik; UYSAL, SALIHA

Assessment of Data Regarding Thalassemias and Hemoglobin Variants From a Tertiary Referral Hospital Laboratory in Turkey

Tevfik BALCI, (Necmettin Erbakan University, Meram Faculty of Medicine, Department of Medical Biochemistry, KONYA, Türkiye)

Merve Sibel GÜNGÖREN, (Necmettin Erbakan University, Meram Faculty of Medicine, Department of Medical Biochemistry,KONYA, Türkiye)

Saliha UYSAL, (Necmettin Erbakan University, Meram Faculty of Medicine, Department of Medical Biochemistry,KONYA, Türkiye)

Nejla ÖZER, (Necmettin Erbakan University, Meram Faculty of Medicine, Department of Medical Biochemistry,KONYA, Türkiye)

Mehmet AKÖZ (Necmettin Erbakan University, Meram Faculty of Medicine, Department of Medical Biochemistry,KONYA, Türkiye)

Türk Klinik Biyokimya Dergisi

6 1

Yıl: 2017 Cilt: 15 Sayı: 2 Sayfa Aralığı: 52 - 66 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Assessment of Data Regarding Thalassemias and Hemoglobin Variants From a Tertiary Referral Hospital Laboratory in Turkey

Öz:

Amaç: Hemoglobinopatiler, globin fonksiyonlarını bozan bir grup hastalıktır. HPLC, hemoglobinopati taramalarında tüm dünyada en sık kullanılan tekniktir. Çalışmada, Türkiye'de bir üçüncü basamak hastane laboratuvarında 3 yıllık retrospektif hemoglobinopati sıklığı değerlendirilmesi amaçlanmıştır. Gereç ve Yöntem: Üniversite hastanemize başvuran 2461 hastanın 3 yıllık laboratuvar ve hastane kayıtları incelenmiştir. Hemoglobinopati taramasında Tosoh G8 HPLC cihazı kullanılmıştır Bulgular: HbA2>%3,5 olan 668, %3,5<HbA2<%4 olan 19 sonuç saptanmıştır.19 sonuçtan 10'u betatalasemi minör olarak kabul edilmiştir. HbA2 >=%4 olan 649 sonuç vardır ve sonculara göre 602 hasta beta-talassemi minör olarak kabul edilmiştir. HbA2 düzeylerine göre, hastaların %25'i beta-talasemi minör olarak değerlendirilmiştir. HbF>%2 olan 391 hasta saptanmış ve HbA2<%3,5 olan 138 kayıt ayrıntılı incelemeye alınmıştır. Varyant analizi veri kümesi, 53 hasta içermektedir. HbA2<=%3,5 ve HbF<=%2 olan, varyant pikleri mevcut kayıtlar incelenmiş ve 28 vaka saptanmıştır. En sık görülen Hb varyantları sırasıyla HbH, HbS, HbD, HbC, HbE ve HbO-Arab'dır. Sonuç: Çalışmada en sık varyantlar sırasıyla HbH, HbAS, HbAD, HbAC, HbAE ve HbO-Arab olarak bulunmuştur. Beta talasemi minör sıklığı ülkemizin gelen popülasyonundan yüksek olarak %25 bulunmuştur. Özellikle hematolojik malignensiler, herediter sferositoz ve demir eksikliği anemisi gibi eşlik eden durumlar hemoglobinopati değerlendirmesinde akılda tutulmalıdır

Anahtar Kelime:

Konular: Biyokimya ve Moleküler Biyoloji

Bir Üniversite Hastanesinde Hemoglobinopati ve Talasemi Verilerinin Değerlendirilmesi

Öz:

Objective: Hemoglobinopathies are an array of disorders that affect hemoglobin (Hb) function. HPLC is by far the most common technique used for detection of hemoglobinopathies worldwide. The aim of this study is to evaluate 3-year retrospective data of a tertiary hospital in Turkey according to prevalence of hemoglobinopathies.Material and Methods: A three-year data of 2461 patients admitted to our university hospital laboratory were assessed by scanning laboratory and hospital records. Tosoh G8 HPLC instrument was used for screening. Results: 668 results with HbA2>3.5% and 19 results with 3.5%< HbA2 <4% were detected. 10 of 19patients were considered as beta-thalassemia. Number of patients with HbA2 ≥4% were 649 and 602 of them were assessed as beta-thalassemia-minor. 25% of patients were assessed as beta-thalassemiaminor, based on HbA2 levels. 391 patient results were found to be HbF>2% and 138 of them with HbA2<3.5% were further investigated. Variant analysis dataset contains 53 patients. Samples with HbA2≤3.5% and HbF≤2% showing variant peaks were scanned and 28 cases were detected. The mostcommon variants were found to be HbH, HbS, HbD, HbC, HbE and HbO-Arab, respectively. Conclusion: In this study, the most common variants were found to be HbH, HbAS, HbAD, HbAC, HbAE and HbO-Arab, respectively. Moreover, the frequency of beta-thalassemia minor was found as 25% which is higher than general population prevalence of our country. Accompanying diseases especially hematological malignancies, hereditary spherocytosis and IDA should be kept in mind during evaluating hemoglobinopathy analysis.

Anahtar Kelime:

Konular: Biyokimya ve Moleküler Biyoloji

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010; 33(1): 62-9.
2. Nathan DM, Davidson MB, DeFronzo RA, et al, for the American Diabetes Association. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 2007; 30: 753– 59.
3. Abdul-Ghani MA, Tripathy D, DeFronzo RA. Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care 2006; 29: 1130-1139.
4. Teegarden D, Donkin SS. Vitamin D: emerging new roles in insulin sensitivity. Nutr Res Rev 2009; 22: 82-92.
5. Muszkat P, Camargo MB, Griz LH, Lazaretti-Castro M. Evidence-based non-skeletal actions of vitamin D. Arq Bras Endocrinol Metabol 2010; 54: 110-117.
6. Scragg R, Holdaway I, Singh V, Metcalf P, Baker J, Dryson E. Serum 25-hydroxyvitamin D3 levels decreased in impaired glucose tolerance and diabetes mellitus. DiabetesResearch and Clinical Practice 1995; 27(3): 181–18
7. Baynes KCR, Boucher BJ, Feskens EJM, Kromhout D. Vitamin D, glucose tolerance anal insulinaemia in elderly men. Diabetologia 1997; 40(3): 344–347.
8. Scragg R, Sowers M, Bell C. Serum 25- hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 2004; 27(12): 2813–2818.
9. Chertow BS, Sivitz WI, Baranetsky NG, Clark SA, Waite A. Cellular mechanisms of insulin release: the effects of vitamin D deficiency and repletion on rat insulin secretion. Endocrinology 1983, 113:1511– 1518.
10. Pittas AG, Harris SS, Stark PC, Dawson-Hughes B. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care 2007; 30(4): 980-6
11. von Hurst PR, Stonehouse W, Coad J. Vitamin D supplementation reduces insülin resistance in South Asian Women living New Zealand who are insülin resistant and vitamin D deficient-a randomised, placebo-controlled trial. Br J Nutr 2010; 103: 549-555
12. de Courten B, Mousa A, Naderpoor N, Teede H, de Courten MP, Scragg R. Vitamin D supplementation for the prevention of type 2 diabetes in overweight adults: study protocol for a randomized controlled trial. Trials. 2015 Aug 7;16:335.
13. Mathieu C, Gysemans C, Giulietti A, Bouillon R. Vitamin D and diabetes. Diabetologia 2005;48(7): 1247-1257
14. Ogunkolade BW, Boucher BJ, Prahl JMet, al. Vitamin D receptor (VDR) mRNA and VDR protein levels in relation to vitamin D status, insulin secretory capacity, and VDR genotype in Bangladeshi Asians. Diabetes 2002; 51: 2294– 2300.
15. Uitterlinden AG, Fang Y, van Meurs JBJ, et al. Genetics and biology of vitamin D receptor polymorphisms. Gene 2004; 338:143–156.
16. Liu E, Meigs JB, Pittas AG, et al. Plasma 25- hydroxyvitamin d is associated with markers of the insulin resistant phenotype in nondiabetic adults. J Nutr 2009;139(2): 329-334.
17. Chiu KC, Chu A, Go AWL, Saad MF. Hypovitaminosis D is associated with insulin resistance and  cell dysfunction. American Journal of Clinical Nutrition. 2004;79(5): 820–825.
18. Yang Y, Zhang X, Bao M, et al. Effect of serum 25- hydroxyvitamin D3 on insulin resistance and -cell function in newly diagnosed type 2 diabetes patients. J Diabetes Investig. 2016 Mar;7(2):226-32
19. Need AG, O Loughlin PD, Horowitz M, Nordin BE. Relationship between fasting serum glucose, age, body mass index and serum 25 hydroxyvitamin D in postmenopausal women. Clin Endocrinol (Oxf) 2005; 62: 738–741.
20. Macdonald HM, Mavroeidi A, Barr RJ, Black AJ, Fraser WD, Reid DM. Vitamin D status in postmenopausal women living at higher latitudes in the UK in relation to bone health, overweight, sunlight exposure and dietary vitamin D. Bone 2008,42:996–1003.
21. Konradsen S, Ag H, Lindberg F, Hexeberg S, Jorde R. Serum 1,25-dihydroxy vitamin D is inversely associated with body mass index. EurJ Nutr 2008; 47: 87–91.
22. Ford ES, Ajani UA, McGuire LC, Liu S. Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care 2005; 28:1228–1230.
23. Dawson-Hughes B, Harris S, Dallal G. Plasma calcidiol, season, and serum parathyroid hormone concentrations in healthy elderly men and women. Am J Clin Nutr 1997;65(1):67–71
24. Heshmat R, Tabatabaei-Malazy O, AbbaszadehAhranjani S, et al. Effect of vitamin D on insulin resistance and anthropometric parameters in Type 2 diabetes; a randomized double-blind clinical trial. DARU Journal of Pharmaceutical Sciences 2012; 20(1):10
25. Bellan M, Guzzaloni G, Rinaldi M, et al. Altered glucose metabolism rather than naive type 2 diabetes mellitus (T2DM) is related to vitamin D status in severe obesity. Cardiovasc Diabetol. 2014 Mar 11;13:57. doi: 10.1186/1475-2840-13-57.
26. Shankar A, Sabanayagam C, Kalindi S. Serum 25- hydroxyvitamin D levels and prediabetes among subjects free of diabetes. Diabetes Care 2011; 34: 1114-1119
27. Pittas AG, Chung M, Trikalinos T, et al. Systematic review: Vitamin D and cardiometabolic outcomes. Ann Intern Med 2010;152:307-314
28. Tsur A, Feldman BS, Feldhammer I, Hoshen MB, Leibowitz G, Balicer RD. Decreased serum concentrations of 25-hydroxycholecalciferol are associated with increased risk of progression to impaired fasting glucose and diabetes.Diabetes Care. 2013; 36(5):1361-7.
29. Hutchinson MS, Figenschau Y, Almås B, Njølstad I, Jorde R. Serum 25-hydroxyvitamin D levels in subjects with reduced glucose tolerance and type 2 diabetes - the Tromsø OGTT-study. Int J Vitam Nutr Res 2011; 81(5): 317-27.
30. Pittas AG, Nelson J, Mitri J, et al. Diabetes Prevention Program Research Group. Plasma 25- hydroxyvitamin D and progression to diabetes in patients at risk for diabetes: an ancillary analysis in the Diabetes Prevention Program. Diabetes Care. 2012; 35(3): 565-73

APA	BALCI T, GÜNGÖREN M, UYSAL S, ÖZER N, AKÖZ M (2017). Assessment of Data Regarding Thalassemias and Hemoglobin Variants From a Tertiary Referral Hospital Laboratory in Turkey. , 52 - 66.
Chicago	BALCI Tevfik,GÜNGÖREN Merve Sibel,UYSAL SALIHA,ÖZER Nejla,AKÖZ MEHMET Assessment of Data Regarding Thalassemias and Hemoglobin Variants From a Tertiary Referral Hospital Laboratory in Turkey. (2017): 52 - 66.
MLA	BALCI Tevfik,GÜNGÖREN Merve Sibel,UYSAL SALIHA,ÖZER Nejla,AKÖZ MEHMET Assessment of Data Regarding Thalassemias and Hemoglobin Variants From a Tertiary Referral Hospital Laboratory in Turkey. , 2017, ss.52 - 66.
AMA	BALCI T,GÜNGÖREN M,UYSAL S,ÖZER N,AKÖZ M Assessment of Data Regarding Thalassemias and Hemoglobin Variants From a Tertiary Referral Hospital Laboratory in Turkey. . 2017; 52 - 66.
Vancouver	BALCI T,GÜNGÖREN M,UYSAL S,ÖZER N,AKÖZ M Assessment of Data Regarding Thalassemias and Hemoglobin Variants From a Tertiary Referral Hospital Laboratory in Turkey. . 2017; 52 - 66.
IEEE	BALCI T,GÜNGÖREN M,UYSAL S,ÖZER N,AKÖZ M "Assessment of Data Regarding Thalassemias and Hemoglobin Variants From a Tertiary Referral Hospital Laboratory in Turkey." , ss.52 - 66, 2017.
ISNAD	BALCI, Tevfik vd. "Assessment of Data Regarding Thalassemias and Hemoglobin Variants From a Tertiary Referral Hospital Laboratory in Turkey". (2017), 52-66.

APA	BALCI T, GÜNGÖREN M, UYSAL S, ÖZER N, AKÖZ M (2017). Assessment of Data Regarding Thalassemias and Hemoglobin Variants From a Tertiary Referral Hospital Laboratory in Turkey. Türk Klinik Biyokimya Dergisi, 15(2), 52 - 66.
Chicago	BALCI Tevfik,GÜNGÖREN Merve Sibel,UYSAL SALIHA,ÖZER Nejla,AKÖZ MEHMET Assessment of Data Regarding Thalassemias and Hemoglobin Variants From a Tertiary Referral Hospital Laboratory in Turkey. Türk Klinik Biyokimya Dergisi 15, no.2 (2017): 52 - 66.
MLA	BALCI Tevfik,GÜNGÖREN Merve Sibel,UYSAL SALIHA,ÖZER Nejla,AKÖZ MEHMET Assessment of Data Regarding Thalassemias and Hemoglobin Variants From a Tertiary Referral Hospital Laboratory in Turkey. Türk Klinik Biyokimya Dergisi, vol.15, no.2, 2017, ss.52 - 66.
AMA	BALCI T,GÜNGÖREN M,UYSAL S,ÖZER N,AKÖZ M Assessment of Data Regarding Thalassemias and Hemoglobin Variants From a Tertiary Referral Hospital Laboratory in Turkey. Türk Klinik Biyokimya Dergisi. 2017; 15(2): 52 - 66.
Vancouver	BALCI T,GÜNGÖREN M,UYSAL S,ÖZER N,AKÖZ M Assessment of Data Regarding Thalassemias and Hemoglobin Variants From a Tertiary Referral Hospital Laboratory in Turkey. Türk Klinik Biyokimya Dergisi. 2017; 15(2): 52 - 66.
IEEE	BALCI T,GÜNGÖREN M,UYSAL S,ÖZER N,AKÖZ M "Assessment of Data Regarding Thalassemias and Hemoglobin Variants From a Tertiary Referral Hospital Laboratory in Turkey." Türk Klinik Biyokimya Dergisi, 15, ss.52 - 66, 2017.
ISNAD	BALCI, Tevfik vd. "Assessment of Data Regarding Thalassemias and Hemoglobin Variants From a Tertiary Referral Hospital Laboratory in Turkey". Türk Klinik Biyokimya Dergisi 15/2 (2017), 52-66.